BAYRY
Price
$8.14
Change
-$0.08 (-0.97%)
Updated
Aug 28 closing price
Capitalization
32.49B
74 days until earnings call
BIIB
Price
$132.65
Change
-$3.71 (-2.72%)
Updated
Aug 28 closing price
Capitalization
19.45B
54 days until earnings call
Interact to see
Advertisement

BAYRY vs BIIB

Header iconBAYRY vs BIIB Comparison
Open Charts BAYRY vs BIIBBanner chart's image
Bayer A.G
Price$8.14
Change-$0.08 (-0.97%)
Volume$303.24K
Capitalization32.49B
Biogen
Price$132.65
Change-$3.71 (-2.72%)
Volume$1.56M
Capitalization19.45B
BAYRY vs BIIB Comparison Chart in %
Loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAYRY vs. BIIB commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAYRY is a Hold and BIIB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BAYRY: $8.14 vs. BIIB: $132.65)
Brand notoriety: BAYRY: Not notable vs. BIIB: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BAYRY: 37% vs. BIIB: 113%
Market capitalization -- BAYRY: $32.49B vs. BIIB: $19.45B
BAYRY [@Pharmaceuticals: Major] is valued at $32.49B. BIIB’s [@Pharmaceuticals: Major] market capitalization is $19.45B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAYRY’s FA Score shows that 0 FA rating(s) are green whileBIIB’s FA Score has 0 green FA rating(s).

  • BAYRY’s FA Score: 0 green, 5 red.
  • BIIB’s FA Score: 0 green, 5 red.
According to our system of comparison, BAYRY is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAYRY’s TA Score shows that 7 TA indicator(s) are bullish while BIIB’s TA Score has 4 bullish TA indicator(s).

  • BAYRY’s TA Score: 7 bullish, 3 bearish.
  • BIIB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BAYRY is a better buy in the short-term than BIIB.

Price Growth

BAYRY (@Pharmaceuticals: Major) experienced а +0.49% price change this week, while BIIB (@Pharmaceuticals: Major) price change was -4.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.18%. For the same industry, the average monthly price growth was +0.54%, and the average quarterly price growth was +11.97%.

Reported Earning Dates

BAYRY is expected to report earnings on Nov 11, 2025.

BIIB is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.18% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYRY($32.5B) has a higher market cap than BIIB($19.4B). BAYRY YTD gains are higher at: 67.598 vs. BIIB (-13.255). BAYRY has higher annual earnings (EBITDA): 6.84B vs. BIIB (2.79B). BAYRY has more cash in the bank: 5.5B vs. BIIB (2.76B). BAYRY has higher revenues than BIIB: BAYRY (46.2B) vs BIIB (10B).
BAYRYBIIBBAYRY / BIIB
Capitalization32.5B19.4B168%
EBITDA6.84B2.79B245%
Gain YTD67.598-13.255-510%
P/E RatioN/A12.69-
Revenue46.2B10B462%
Total Cash5.5B2.76B199%
Total DebtN/A6.6B-
FUNDAMENTALS RATINGS
BAYRY vs BIIB: Fundamental Ratings
BAYRY
BIIB
OUTLOOK RATING
1..100
7116
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4659
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAYRY's Valuation (87) in the null industry is in the same range as BIIB (89) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's Profit vs Risk Rating (100) in the null industry is in the same range as BIIB (100) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's SMR Rating (100) in the null industry is in the same range as BIIB (100) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's Price Growth Rating (46) in the null industry is in the same range as BIIB (59) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's P/E Growth Rating (100) in the null industry is in the same range as BIIB (100) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAYRYBIIB
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
57%
Advances
ODDS (%)
Bullish Trend 11 days ago
61%
Bullish Trend 7 days ago
53%
Declines
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
69%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BULZ201.634.90
+2.49%
MicroSectors™ Slct FANG Inn 3X Lvgd ETNs
BEGS34.510.07
+0.22%
Rareview 2X Bull Cryptoccy & Prc Mtl ETF
JULW38.030.07
+0.19%
AllianzIM US Large Cap Buffer20 Jul ETF
BUL53.080.08
+0.14%
Pacer US Cash Cows Growth ETF
BEEZ33.680.01
+0.04%
Honeytree U.S. Equity ETF

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
-0.97%
BAYZF - BAYRY
88%
Closely correlated
N/A
OPHLY - BAYRY
23%
Poorly correlated
+2.77%
SNY - BAYRY
23%
Poorly correlated
-0.34%
AZN - BAYRY
21%
Poorly correlated
+0.08%
BIIB - BAYRY
20%
Poorly correlated
-2.72%
More